Russian lab touts MRNA cancer vaccine by end of year — RT Russia & Former Soviet Union
The breakthrough treatment is expected to get regulatory approval by August, according to the head of the Gamaleya Research Institute
Read moreThe breakthrough treatment is expected to get regulatory approval by August, according to the head of the Gamaleya Research Institute
Read morePart 1 of our recap of Bitcoin developments in 2024 included the launch of US-based spot ETFs, the halving, and
Read morePhoto by Nick Owuor (astro.nic.portraits) on Unsplash If you invested $1 in Bitcoin in 2010, it would be worth approximately
Read moreTom Lee, co-founder and managing partner at Fundstrat, has expressed confidence in bitcoin’s long-term prospects. Although the cryptocurrency currently sits
Read moreNate Geraci, a well-known exchange-traded fund analyst, has predicted that 2025 will be the year of crypto ETFs. He expects
Read moreFidelity predicts 2025 will ignite a seismic shift as nation-states, banks, and institutions race to embrace bitcoin, marking the dawn
Read moreOn Jan. 12, 2025, bitcoin’s price has been drifting within the $95,000 range, while market participants on prediction platforms such
Read moreBitcoin reached an inflection point in 2024, definitively leaving behind its reputation as a speculative asset and cementing its position
Read moreThe past year has been a “turning point,” but the next 12 months will bring even more upheaval By Vitaly Ryumshin,
Read moreKey Takeaways Polymarket bettors predict a 78% chance of SEC approval for Solana ETFs in 2025. Five asset managers have
Read more